Two DLTs, deemed to be pemetrexed-related, were observed at dose level A4 (grade 4 cytopenias [including leucopenia, neutropenia, lymphopenia, and thrombocytopenia] and grade 3 increases in ALT and AST). This evidence concerns the gene GPT and neutropenia.